Holdings of SR One Capital Management, LP
11 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 99.6 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 11 | 796.3M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Arcellx Inc | 2,346,630 | 269.4M $ | |
| 2 | VeraDermics Inc | 2,401,868 | 151.7M $ | |
| 3 | ZENAS BIOPHARMA INC | 5,037,854 | 98.5M $ | |
| 4 | Design Therapeutics Inc | 6,526,476 | 69.4M $ | |
| 5 | ORIC Pharmaceuticals Inc | 4,514,929 | 58.5M $ | |
| 6 | Alumis Inc | 1,959,896 | 43.2M $ | |
| 7 | Mineralys Therapeutics Inc | 1,563,966 | 42.4M $ | |
| 8 | ARS Pharmaceuticals Inc | 4,012,903 | 32.2M $ | |
| 9 | Oruka Therapeutics Inc | 430,330 | 21.1M $ | |
| 10 | Nkarta Inc | 3,333,333 | 7M $ | |
| 11 | Ultragenyx Pharmaceutical Inc | 137,753 | 2.9M $ |